They work so well for one thing because, it turns out, there are more GLP-1 receptors located all over the body than originally thought, and all have positive health benefits when activated
CrossRef Recognizing the Burden of Metabolic Liver Disease in IBD Raseen Tariq, Richard K Sterling Inflammatory Bowel Diseases .2026
in vitro and animal studies have linked thymosin beta-4 overexpression to increased tumor size and metastasis in several cancer types (including colorectal and pancreatic cancer), leading researchers to flag a theoretical cancer-promotion risk, particularly for anyone with an active malignancy or recent cancer history Self-reported effects compiled from user and case reports, not controlled trials, include injection-site redness or itching, transient fatigue, and headache
Individual participant data will be shared in data sets in a de-identified/anonymised format
Patients were presented with the option to get their life-changing weight-loss medication for way less than $1,000 a month, side-stepping insurance
These medications belong to a class of treatments known as GLP-1 receptor agonists and dual GLP-1/GIP receptor agonists, both of which help patients achieve gradual, sustainable weight loss while improving overall metabolic health